Immunochemistry and Immunology of the Cervix

The Cervix: Second Edition

Volumn , Issue , 2009, Pages 49-61

  Stanley, Margaret A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cell adhesion molecules (CAMs); Cell cell adhesion; Cell matrix adhesion; Immunochemistry and immunology of cervix; Keratin expression in cervical epithelia; MHC class II expression; Non keratinising squamous epithelium

Indexed keywords

EID: 70350134806     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444312744.ch4     Document Type: Chapter

References (69)

1. al Saleh W, Delvenne P, van den Brule FA et al. (1997) Expression of the 67 KD laminin receptor in human cervical preneoplastic and neoplastic squamous epithelial lesions: an immunohistochemical study. Journal of Pathology 181: 287-293.
2. al Saleh W, Giannini SL, Jacobs N et al. (1998) Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix. Journal of Pathology 184: 283-290.
3. Alazawi W, Pett M, Arch B et al. (2002) Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16. Cancer Research 62: 6959-6965.
4. Alazawi WO, Morris L, Garrod D et al. (2003) Immunohistochemical staining of desmosomal components in cervical intra-epithelial neoplasia. Virchows Archiv 443: 51-56.
5. Bachmann A, Hanke B, Zawatzky S et al. (2002) Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells. Journal of Virology 76: 280-91.
6. Barnard P, McMillan NA (1999) The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha. Virology 259: 305-313.
7. Bartholomew JS, Glenville S, Sarkar S et al. (1997) Integration of highrisk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells. Cancer Research 57: 937-942.
8. Barton SE, Maddox PH, Jenkins D et al. (1988) Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change? Lancet ii: 652-654.
9. Bell MC, Edwards RP, Partridge EE et al. (1995) CD8+ T lymphocytes are recruited to neoplastic cervix. Journal of Clinical Immunology 15: 130-136.
10. Bontkes HJ, de Gruijl TD, Walboomers JM et al. (1997) Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions. British Journal of Cancer 76: 1353-1360.
11. Bontkes HJ, Walboomers JM, Meijer CJ et al. (1998) Specific HLA class I down-regulation is an early event in cervical dysplasia associated with clinical progression. Lancet 351: 187-188.
12. Brown DC, Gatter KC (1990) Monoclonal antibody Ki-67: its use in histopathology. Histopathology 17: 489-503.
13. Chang YE, Laimins LA (2000) Microarray analysis identifies interferoninducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. Journal of Virology 74: 4174-4182.
14. Chang YE, Pena L, Sen GC et al. (2002) Long-term effect of interferon on keratinocytes that maintain human papillomavirus type 31. Journal of Virology 76: 8864-8874.
15. Coleman N (1993) The local immune response to human papilloma virus related disease in the female genital tract. PhD Thesis, University of Cambridge, UK.
16. Coleman N, Stanley MA (1994a) Characterization and functional analysis of the expression of vascular adhesion molecules in human papillomavirus related disease of the cervix. Cancer 74: 884-892.
17. Coleman N, Stanley MA (1994b) Analysis of HLA DR expression on keratinocytes in cervical neoplasia. International Journal of Cancer 56: 314-319.
18. Coleman N, Greenfield IM, Hare J et al. (1993) Characterization and functional analysis of the expression of intercellular adhesion molecule 1 in human papillomavirus related disease of cervical keratinocytes. American Journal of Pathology 143: 355-367.
19. Comerci JT Jr, Runowicz CD, Flanders KC et al. (1996) Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix. Cancer 77: 1107-1114.
20. Cromme FV, Meijer CJ, Snijders PJ et al. (1993a) Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions. British Journal of Cancer 67: 1372-1380.
21. Cromme FV, Snijders PJ, Van Den Brule AJ et al. (1993b) MHC class I expression in HPV 16 positive cervical carcinomas is post transcriptionally controlled and independent from c myc overexpression. Oncogene 8: 2969-2975.
22. Cromme FV, Airey J, Heemels M-T et al. (1994) Loss of transporter protein encoded by the TAP-1 gene is highly correlated with loss of HLA expression in cervical carcinomas. Journal of Experimental Medicine 179: 335-340.
23. de Boer CJ, van Dorst E, van Krieken H et al. (1999) Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix. American Journal of Pathology 155: 505-515.
24. de Gruijl TD, Bontkes HJ, van den Muysenberg AJ et al. (1999) Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix. European Journal of Cancer 35: 490-497.
25. Dixon IS, Stanley MA (1984) Immunofluorescent studies of human cervical epithelia in vitro using antibodies against specific keratin components. Molecular Biology and Medicine 2: 37-51.
26. Dowen SE, Scott A, Mukherjee G et al. (2003) Over expression of SKP2 in carcinoma of the cervix does not correlate inversely with p27 expression. International Journal of Cancer 22: 2531-2540.
27. Edwards RP, Kuykendall K, Crowley-Nowick P et al. (1995) T lymphocytes infiltrating advanced grades of cervical neoplasia. CD8-positive cells are recruited to invasion. Cancer 76: 1411-1415.
28. Freeman A, Morris LS, Mills AD et al. (1999) Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clinical Cancer Research 5: 2121-2132.
29. Giannini SL, Hubert P, Doyen J et al. (2002) Influence of the mucosal epithelium microenvironment on Langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix. International Journal of Cancer 97: 654-659.
30. Gigi Leitner O, Geiger B, Levy R et al. (1986) Cytokeratin expression in metaplasia of the human cervix. Differentiation 31: 191-205.
31. Glew SS, Connor ME, Snijders PJ et al. (1993) HLA expression in pre invasive cervical neoplasia in relation to human papilloma virus infection. European Journal of Cancer 29A: 1963-1970.
32. Hawthorn RJ, Murdoch JB, MacLean AB et al. (1988) Langerhans' cells and subtypes of human papillomavirus in cervical intraepithelial neoplasia. British Medical Journal 297: 643-646.
33. Hilders CGJM, Houbiers JGA, Krul EJT et al. (1994) The expression of histocompatability-related leukocyte antigens in the pathway to cervical carcinoma. American Journal of Clinical Pathology 101: 5-12.
34. Huang LW, Chao SL, Hwang JL et al. (2002) Down-regulation of p27 is associated with malignant transformation and aggressive phenotype of cervical neoplasms. Gynecologic Oncology 85: 524-528.
35. Hubert P, van den Brule F, Giannini SL et al. (1999) Colonization of in vitro-formed cervical human papillomavirus-associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colonystimulating factor. American Journal of Pathology 154: 775-784.
36. Hughes DE, Rebello G, Al-Nafussi A (1994) Integrin expression in squamous neoplasia of the cervix. Journal of Pathology 173: 97-104.
37. Ivanyi D, Groeneveld E, Van Doornewaard G et al. (1990) Keratin subtypes in carcinomas of the uterine cervix: implications for histogenesis and differential diagnosis. Cancer Research 50: 5143-5152.
38. Johansson EL, Rudin A, Wassen L et al. (1999) Distribution of lymphocytes and adhesion molecules in human cervix and vagina. Immunology 96: 272-277.
39. Kanai M, Shiozawa T, Xin L et al. (1998) Immunohistochemical detection of sex steroid receptors, cyclins, and cyclin-dependent kinases in the normal and neoplastic squamous epithelia of the uterine cervix. Cancer 82: 1709-1719.
40. Klaes R, Friedrich T, Spitkovsky D et al. (2001) Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. International Journal of Cancer 92: 276-284.
41. Kobayashi A, Greenblatt RM, Anastos K et al. (2004) Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Cancer Research 64: 6766-6774.
42. Le Bon A, Tough DF (2002) Links between innate and adaptive immunity via type I interferon. Current Opinion in Immunology 14: 432-436.
43. Levy R, Czernobilsky B, Geiger B (1988) Subtyping of epithelial cells of normal and metaplastic human uterine cervix, using polypeptide specific cytokeratin antibodies. Differentiation 39: 185-196.
44. Li S, Labrecque S, Gauzzi MC et al. (1999) The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 18: 5727-5737.
45. McKenzie J, King A, Hare J et al. (1991) Immunocytochemical characterization of large granular lymphocytes in normal cervix and HPV associated disease. Journal of Pathology 165: 75-80.
46. Man S (2005) CD8+ T cell responses against oncogenic papillomariruses-are they useful? Papillomavirus Reports 16: 1-6.
47. Matthews K, Leong CM, Baxter L et al. (2003) Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin. Journal of Virology 77: 8378-8385.
48. Moll R, Franke WW, Schiller DL et al. (1982) The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31: 11-24.
49. Moll R, Levy R, Czernobilsky B et al. (1983) Cytokeratins of normal epithelia and some neoplasms of the female genital tract. Laboratory Investigation 49: 599-610.
50. Mota F, Rayment N, Chong S et al. (1999) The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium. Clinical and Experimental Immunology 116: 33-40.
51. Nees M, Geoghegan JM, Hyman T et al. (2001) Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. Journal of Virology 75: 4283-4296.
52. Nordstrom B, Einhorn N, Silfersvard C et al. (2002) Laminin-5 gamma 2 chain as an invasivity marker for unifocal and multifocal lesions in the lower ano-genital tract. International Journal of Gynecological Cancer 12: 105-109.
53. Poppe WA, Drijkoningen M, Ide PS et al. (1998) Lymphocytes and dendritic cells in the normal uterine cervix. An immunohistochemical study. European Journal of Obstetrics, Gynecology, and Reproductive Biology 81: 277-282.
54. Roncalli M, Sideri M, Gie P et al. (1988) Immunophenotypic analysis of the transformation zone of human cervix. Laboratory Investigation 58: 141-149.
55. Sano T, Oyama T, Kashiwabara K et al. (1998) Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. American Journal of Pathology 153: 1741-1748.
56. Santin AD, Hermonat PL, Ravaggi A et al. (2001) Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells. Clinical Cancer Research 7: 804s-810s.
57. Sheu BC, Lin RH, Lien HC et al. (2001) Predominant Th2/Tc2 polarity of tumor infiltrating lymphocytes in human cervical cancer. Journal of Immunology 167: 2972-2978.
58. Shiozawa T, Shiohara S, Kanai M et al. (2001) Expression of the cell cycle regulator p27(Kip1) in normal squamous epithelium, cervical intraepithelial neoplasia, and invasive squamous cell carcinoma of the uterine cervix. Immunohistochemistry and functional aspects of p27(Kip1). Cancer 92: 3005-3011.
59. Smedts F, Ramaekers F, Robben H et al. (1990) Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia. American Journal of Pathology 136: 657-668.
60. Smedts F, Ramaekers F, Troyanovsky S et al. (1992) Basal cell keratins in cervical reserve cells and a comparison to their expression in cervical intraepithelial neoplasia. American Journal of Pathology 140: 601-612.
61. Smedts F, Ramaekers F, Leube RE et al. (1993) Expression of keratins 1, 6, 15, 16, and 20 in normal cervical epithelium, squamous metaplasia, cervical intraepithelial neoplasia, and cervical carcinoma. American Journal of Pathology 142: 403-412.
62. Stanley MA (2001) Immune responses to human papillomaviruses. In: Sterling JC, Tyring SK (eds) Human Papillomaviruses. Clinical and Scientific Advances. London: Arnold, pp. 38-49.
63. Stanley M, Coleman N, Chambers M (1994) The host response to lesions induced by human papillomavirus. Ciba Foundation Symposium 187: 21-32; discussion 32-44.
64. Stanley MA, Scarpini C, Coleman N (2003) Cell mediated immunity and lower genital tract neoplasia. In: McLean AB, Singer A, Critchley H (eds) Lower Genital Tract Neoplasia. London: RCOG Press, pp. 27-44.
65. Szarewski A, Maddox P, Royston P et al. (2001) The effect of stopping smoking on cervical Langerhans' cells and lymphocytes. British Journal of Obstetrics and Gynaecology 108: 295-303.
66. Tay SK, Jenkins D, Maddox P et al. (1987) Lymphocyte phenotypes in cervical intraepithelial neoplasia and human papillomavirus infection. British Journal of Obstetrics and Gynaecology 94: 16-21.
67. Vessey CJ, Wilding J, Folarin N et al. (1995) Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. Journal of Pathology 176: 151-159.
68. Viac J, Guerin Reverchon I, Chardonnet Y et al. (1990) Langerhans cells and epithelial cell modifications in cervical intraepithelial neoplasia: correlation with human papillomavirus infection. Immunobiology 180: 328-338.
69. Warhol MJ, Gee B (1989) The expression of histocompatibility antigen HLA DR in cervical squamous epithelium infected with human papilloma virus. Modern Pathology 2: 101-104.